Hu23F2G, an Antibody Recognizing the Leukocyte CD11/CD18 Integrin, Reduces Injury in a Rabbit Model of Transient Focal Cerebral Ischemia
Open Access
- 1 October 1998
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 153 (2) , 223-233
- https://doi.org/10.1006/exnr.1998.6876
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Antibodies against Adhesion Molecules Reduce Apoptosis after Transient Middle Cerebral Artery Occlusion in Rat BrainJournal of Cerebral Blood Flow & Metabolism, 1996
- IB4, a monoclonal antibody against the CD18 leukocyte adhesion protein, reduces intracranial pressure following thromboembolic stroke in the rabbitNeurological Research, 1996
- Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapyNeurology, 1995
- Reperfusion following focal stroke hastens inflammation and resolution of ischemic injured tissueBrain Research Bulletin, 1994
- Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats.Stroke, 1994
- Anti‐CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in ratAnnals of Neurology, 1994
- Monoclonal Antibody to the ICAM-1 Adhesion Site Reduces Neurological Damage in a Rabbit Cerebral Embolism Stroke ModelExperimental Neurology, 1993
- Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion moleculeJournal of Neurosurgery, 1991
- Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment.Stroke, 1991
- Structure and function of the leukocyte adhesion molecules CD11/CD18Blood, 1990